Sign Up to like & get
recommendations!
0
Published in 2017 at "Bioorganic chemistry"
DOI: 10.1016/j.bioorg.2017.04.001
Abstract: In our efforts to develop novel dual c-Met/VEGFR-2 inhibitors as potential anticancer agents, a series of 2-substituted-4-(2-fluorophenoxy) pyridine derivatives bearing pyrazolone scaffold were designed and synthesized. The cell proliferation assay in vitro demonstrated that most…
read more here.
Keywords:
substituted fluorophenoxy;
met vegfr;
fluorophenoxy pyridine;
dual met ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Oncogene"
DOI: 10.1038/onc.2016.283
Abstract: Amplification of the MET oncogene occurs in 2–4% of gastroesophageal cancers and defines a small and aggressive subset of tumors. Although in vitro studies have given very promising results, clinical trials with MET inhibitors have…
read more here.
Keywords:
met egfr;
egfr therapy;
resistance;
dual met ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Journal of Enzyme Inhibition and Medicinal Chemistry"
DOI: 10.1080/14756366.2023.2189578
Abstract: Abstract The dual c-Met/vascular endothelial growth factor receptor 2 (VEGFR-2) TK inhibition is a good strategy to overcome therapeutic resistance to small molecules VEGFR-2 inhibitors. In this study, we designed 3-substituted quinazoline-2,4(1H,3H)-dione derivatives as dual…
read more here.
Keywords:
substituted quinazoline;
dione derivatives;
quinazoline dione;
dual met ... See more keywords